Abstract
Sickle cell disease is characterized by vaso-occlusive phenomena and haemolytic anaemia. There is a significant concern that the overlap of COVID-19 lung disease with acute chest syndrome that occurs in sickle cell patients may result in serious complications. Case reports of sickle cell patients with COVID-19 have been published. Here, we present a case series of COVID-19 infection in sickle cell patients in a developing country (Brazil). Only 10 patients tested positive so far for SARS-CoV-2 of 600 patients followed at our institution, of which 8 needed hospitalization (one in the intensive care unit), with no deaths. Even in a middle-income country, COVID-19 was reported to be relatively mild in sickle cell patients. In relation to risk factors, blood type O seems to confer some protection against developing severe COVID-19, a finding that could guide clinicians to adopt more clinical surveillance for patients with non-O blood type in sickle cell patients.
References
1.
Bunn
HF
. Pathogenesis and treatment of sickle cell disease
. N Engl J Med
. 1997
;337
:762
. .2.
Rees
DC
, Williams
TN
, Gladwin
MT
. Sickle-cell disease
. Lancet
. 2010
;376
:2018
. .3.
Gladwin
MT
, Vichinsky
E
. Pulmonary complications of sickle cell disease
. N Engl J Med
. 2008
;359
:2254
. .4.
Vichinsky
EP
, Neumayr
LD
, Earles
AN
, Williams
R
, Lennette
ET
, Dean
D
, Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group
. N Engl J Med
. 2000
;342
(25
):1855
–65
. .5.
Pascarella
G
, Strumia
A
, Piliego
C
, Bruno
F
, Del Buono
R
, Costa
F
, COVID-19 diagnosis and management: a comprehensive review
. J Intern Med
. 2020 Aug
;288
(2
):192
–206
. 6.
Hussain
FA
, Njoku
FU
, Saraf
SL
, Molokie
RE
, Gordeuk
VR
, Han
J
. COVID-19 infection in patients with sickle cell disease
. Br J Haematol
. 2020 Jun
;189
(5
):851
–2
. Epub 2020 May 8. PMID: 32314798; PMCID: PMC7264585. .7.
Chakravorty
S
, Padmore-Payne
G
, Ike
F
, Tshibangu
V
, Graham
C
, Rees
D
, COVID-19 in patients with sickle cell disease – a case series from a UK Tertiary Hospital
. Haematologica
. 2020 Nov 1
;105
(11
):2691
–3
. 8.
Arlet
JB
, de Luna
G
, Khimoud
D
, Odièvre
MH
, de Montalembert
M
, Joseph
L
, Prognosis of patients with sickle cell disease and COVID-19: a French experience
. Lancet Haematol
. 2020 Sep
;7
(9
):e632
–4
. 9.
Cançado
RD
, Jesus
JA
. A doença falciforme no Brasil
. Rev Bras Hematol Hemoter
. 2007
;29
(3
):204
–6
.10.
Telfer
P
, De la Fuente
J
, Sohal
M
, Brown
R
, Eleftheriou
P
, Roy
N
, Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients
. Haematologica
. 2020 Nov 1
;105
(11
):2651
–4
. .11.
Cheng
Y
, Cheng
Y
, Cheng
G
, Chui
CH
, Lau
FY
, Chan
PK
, ABO blood group and susceptibility to severe acute respiratory syndrome
. JAMA
. 2005 Mar 23
;293
(12
):1450
–1
. Erratum in: JAMA. 2005 Aug 17;294(7):794. Cheng, Yufeng [corrected to Cheng, Yunfeng]. 12.
Zhao
J
, Yang
Y
, Huang
H
, Li
D
, Gu
D
, Lu
X
, Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility
. Clin Infect Dis
. 2021 Jul 15
;73
(2
):328
–31
. 13.
Severe Covid-19 GWAS Group
; Ellinghaus
D
, Ellinghaus
D
, Degenhardt
F
, Bujanda
L
, Buti
M
, Albillos
A
, Genomewide association study of severe Covid-19 with respiratory failure
. N Engl J Med
. 2020 Oct 15
;383
(16
):1522
–34
. 14.
Li
J
, Wang
X
, Chen
J
, Cai
Y
, Deng
A
, Yang
M
. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia
. Br J Haematol
. 2020 Jul
;190
(1
):24
–7
. .15.
Wu
Y
, Feng
Z
, Li
P
, Yu
Q
. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19
. Clin Chim Acta
. 2020 Jun 17
;509
:220
–3
. .16.
Garibaldi
PMM
, Oliveira
LC
, da Fonseca
BA
, Martins
MA
, Miranda
CH
, Almado
CEL
, Histo-blood group A is a risk factor for severe COVID-19
. Transfus Med
. Epub 2021 Jun 3
. 17.
Franchini
M
, Capra
F
, Targher
G
, Montagnana
M
, Lippi
G
. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications
. Thromb J
. 2007 Sep 25
;5
:14
. .18.
De Santis
GC
, Prata
KL
, Rodrigues
RB
, Sankarankutty
AK
, de Castro e Silva
O
, Covas
DT
. Blood group O patients require more blood transfusion in orthotopic liver transplantation
. Transfus Apher Sci
. 2014 Apr
;50
(2
):312
–3
. .19.
Vasan
SK
, Rostgaard
K
, Majeed
A
, Ullum
H
, Titlestad
KE
, Pedersen
OB
, ABO blood group and risk of thromboembolic and arterial disease: a study of 1.5 million blood donors
. Circulation
. 2016 Mar 3
;133
:1449
–57
. .20.
Guillon
P
, Clément
M
, Sébille
V
, Rivain
JG
, Chou
CF
, Ruvoën-Clouet
N
, Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies
. Glycobiology
. 2008 Dec
;18
(12
):1085
–93
. © 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
